【what burns cleaner kerosene or diesel】Heron Gains on Priority Review Designation for Pain Drug
Shares of
Heron Thewhat burns cleaner kerosene or dieselrapeutics, Inc.
HRTX rose 9.22% on Dec 31 after the company announced that the FDA has accepted the new drug application (NDA) for experimental candidate, HTX-011, which was submitted to the agency on Oct 30, 2018. The FDA also granted the NDA a Priority Review designation.
Notably, the company’s shares gained 37.2% in 2018, while the industry declined 20.4%.
Priority Review designation is given to drugs, which upon approval would result in significant improvements in the safety or effectiveness of the treatment or prevention of serious medical conditions.
Meanwhile, the FDA had indicated that it is currently not planning to hold an advisory committee meeting to discuss this application and the agency has set a Prescription Drug User Fee Act goal date of Apr 30, 2019.
The candidate, which utilizes Heron's proprietary Biochronomer drug delivery technology, is a long-acting, extended-release formulation of the local anesthetic bupivacaine in a fixed-dose combination with the anti-inflammatory meloxicam. It is being evaluated for the management of postoperative pain. The candidate is designed to address both postoperative pain and inflammation in a single administration at the surgical site.
The NDA is supported by data from five phase II clinical trials and two phase III clinical trials that included more than 1,000 patients undergoing five different surgical procedures.
We remind investors that the FDA had earlier granted Breakthrough Therapy designation to HTX-011, based on the results of phase II studies and two completed phase III studies. These studies showed that HTX-011 produced significant reductions in both pain intensity and the need for opioids through 72 hours post-surgery compared to placebo and bupivacaine solution, which is the standard of care. The candidate was also granted Fast Track designation by the FDA in the fourth quarter of 2017.
The results of various studies showed that HTX-011 was more effective in reducing pain than placebo or bupivacaine alone in five diverse surgical models — hernia repair, abdominoplasty, bunionectomy, total knee arthroplasty and breast augmentation.
A tentative approval will be a significant boost for the company. There is a great need for safe, effective and non-addictive options that can decrease opioid exposure, given the current epidemic of opioid abuse that has put companies like Endo International ENDP and Mallinckrodt MNK, among others, under the scanner.
Zacks Rank & Stock to Consider
Heron currently carries a Zacks Rank #3 (Hold). A better-ranked stock in the healthcare sector is Bristol-Myers Squibb Company BMY, which carries a Zacks Rank #2 (Buy). You can see
the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here
.
Story continues
Bristol-Myers’ earnings per share estimates have increased from $4.03 to $4.14 for 2019 over the past 60 days. The company delivered a positive earnings surprise in all the trailing four quarters, the average being 11.99%.
The Hottest Tech Mega-Trend of All
Last year, it generated $8 billion in global revenues. By 2020, it's predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.
See Zacks' 3 Best Stocks to Play This Trend >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.
Click to get this free report
Bristol-Myers Squibb Company (BMY) : Free Stock Analysis Report
Endo International plc (ENDP) : Free Stock Analysis Report
Heron Therapeutics, Inc. (HRTX) : Free Stock Analysis Report
Mallinckrodt public limited company (MNK) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
View comments
-
NeoPhotonics (NPTN) Misses Q3 Earnings EstimatesNokia draws $560 million R&D loan for 5GUS Test Preparation Market 2020-2024 - Increasing Use of Analytical Tools and Emphasis of Online Test Preparation Modes Driving Market DemandTrintech Extends Reporting Capabilities in Its Adra Suite with the Launch of Adra AnalyticsGBP/USD Price Forecast – British Pound Continues to Struggle at Same LevelGlobal Virtual Reality in Aerospace and Defense Thematic Report 2020: Lower Prices and New Launches in 2020 are Expected to Encourage GrowthOprah tour driving Weight Watchers membershipsCrude Oil Price Update – Needs to Hold Major 50% Level at $36.07 to Sustain Upside MomentumeXp World Holdings Appoints Fee Gentry to Board of DirectorsFOREX-Dollar wallows near 2 1/2-year low on vaccine, stimulus optimism
下一篇:Memgen Announces Addition to Board of Directors
- ·Exclusive: StanChart says CEO Winters will stay to execute current strategy
- ·'Unsustainable': Mexico's Pemex buckling under crushing pension debt
- ·Canada job growth slows, impact of new lockdowns still to come
- ·Oprah tour driving Weight Watchers memberships
- ·5 Stocks With Decent Growth Potential to Watch Ahead
- ·Fatalities on commercial passenger aircraft rise in '18
- ·Ingredion Incorporated Reports Third Quarter 2020 Results
- ·SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Sasol Limited of Class Action Lawsuit and Upcoming Deadline - SSL
- ·Organic elderberries recalled over possible salmonella contamination
- ·NEWSMAKER-So near yet so far for Malaysia's Anwar
- ·Newmont (NEM) in Focus: Stock Moves 6.2% Higher
- ·StockBeat: Virus Derails Intu's Rescue Plan
- ·Camber Energy, Inc. and Viking Energy Group, Inc. Amend Definitive Merger Agreement Relating to Their Planned Combination and Provide Update on Status of Merger
- ·Donaldson (DCI) Q1 Earnings & Sales Top Estimates, Decline Y/Y
- ·Transformative Mega Trends Reshaping the Indian ICT Landscape
- ·Has Canadian Pacific Railway (CP) Outpaced Other Transportation Stocks This Year?
- ·Stericycle (SRCL) Tops Q3 Earnings and Revenue Estimates
- ·Helius Medical Technologies, Inc. to Present at Upcoming Investor Conferences in November
- ·Worldwide Artificial Intelligence in Energy Industry to 2024 - Key Drivers, Challenges and Trends
- ·Crown Castle (CCI) Gains As Market Dips: What You Should Know
- ·How Does TCF Financial's (NASDAQ:TCF) P/E Compare To Its Industry, After The Share Price Drop?
- ·Why Consumer Financial Protection Bureau's structure is a real threat to small business, individual liberty
- ·Spirit Hub Announces The Spirit Hub Independent Distillery Preservation Fund, A Non-Profit 501(c)3 to Support Independent Distilleries Around the World
- ·Russia asks for ships disinfection from Iran, Italy and South Korea in Novorossiisk - document
- ·Worldwide Artificial Intelligence in Energy Industry to 2024 - Key Drivers, Challenges and Trends
- ·Asia-Pacific Shares Settle Higher as China Factory Activity Expands Beyond Expectations
- ·SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Peabody Energy Corporation
- ·MORNING BID-Between stimulus euphoria and virus dejection
- ·Castlebar Capital Corp. Announces Termination of LOI Respecting Qualifying Transaction
- ·Why looting, protests and COVID-19 haven't pounded the stock market
- ·Here's What World Precision Machinery Limited's (SGX:B49) P/E Is Telling Us
- ·Coronavirus to have substantial impact on trade: WTO
- ·Shipping Marketplace uShip Lays Off 65 Employees
- ·Apple Tells Staff U.S. Stores to Remain Closed Until Early May
- ·ReSPECT Glioblastoma Clinical Trial Data to be Presented at 2020 Society for Neuro-Oncology Annual Meeting
- ·What Kind Of Shareholders Hold The Majority In Select Bancorp, Inc.'s (NASDAQ:SLCT) Shares?